GI
TBPH icon

GAMMA Investing’s Theravance Biopharma TBPH Stock Holding History

GAMMA Investing’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.1K Sell
535
-125
-19% -$2.07K ﹤0.01% 3260
2026
Q1 		$10.7K Sell
660
-38
-5% -$672 ﹤0.01% 3039
2025
Q4 		$13.1K Buy
698
+136
+24% +$2.26K ﹤0.01% 2847
2025
Q3 		$8.21K Buy
562
+90
+19% +$1.14K ﹤0.01% 2976
2025
Q2 		$5.21K Buy
472
+74
+19% +$719 ﹤0.01% 3100
2025
Q1 		$3.55K Buy
398
+125
+46% +$1.16K ﹤0.01% 3221
2024
Q4 		$2.57K Buy
273
+75
+38% +$682 ﹤0.01% 3145
2024
Q3 		$1.6K Sell
198
-86
-30% -$745 ﹤0.01% 3135
2024
Q2 		$2.41K Sell
284
-150
-35% -$1.35K ﹤0.01% 2833
2024
Q1 		$3.89K Buy
434
+396
+1,042% +$3.67K ﹤0.01% 2518
2023
Q4 		$360 Buy
+38
New +$382 ﹤0.01% 3025

Other funds holding TBPH

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
TIM
Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing's TBPH Position: Q2 2026 in Review

GAMMA Investing reduced its Theravance Biopharma (TBPH) stake by 19% in Q2 2026, selling an estimated $2.07K and leaving 535 shares worth $9.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3260.

GAMMA Investing first reported a position in TBPH in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.1K in Q4 2025. 18 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • GAMMA Investing held 535 shares of Theravance Biopharma worth $9.1K as of Q2 2026.
  • GAMMA Investing sold 125 Theravance Biopharma shares in Q2 2026, an estimated $2.07K.
  • Theravance Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3260 holding.
  • GAMMA Investing first reported a position in Theravance Biopharma in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Theravance Biopharma position peaked at $13.1K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.